Ehlers-Danlos syndrome, classic type, 1: genes and variants
Explore variant evidence for Ehlers-Danlos syndrome, classic type, 1 across 4 analyzed proteins (COL1A2, COL5A1, COL5A2, COL1A1). Linked ClinVar records include 296 pathogenic or likely pathogenic variants, 1,416 variants of uncertain significance and 564 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Ehlers-Danlos syndrome, classic type, 1
COL1A2: Collagen alpha-2(I) chain
It contributes one of the three chains of type I collagen, providing tensile strength to bone, skin, tendon, blood vessels, and other connective tissues. Pathogenic variants can cause osteogenesis imperfecta, Ehlers-Danlos phenotypes, and related connective-tissue disorders.
265 ClinVar pathogenic / likely pathogenic and 481 uncertain variants in COL1A2 have source records linked to Ehlers-Danlos syndrome, classic type, 1. Association strength is not clinical gene validity.
COL5A1: Collagen alpha-1(V) chain
It helps nucleate and regulate type I collagen fibril assembly, controlling fibril diameter and connective-tissue architecture. Haploinsufficiency or structural variants are a major cause of classical Ehlers-Danlos syndrome, with skin hyperextensibility, atrophic scarring, and joint hypermobility.
19 ClinVar pathogenic / likely pathogenic and 862 uncertain variants in COL5A1 have source records linked to Ehlers-Danlos syndrome, classic type, 1. Association strength is not clinical gene validity.
COL5A2: Collagen alpha-2(V) chain
It partners with COL5A1-derived chains to regulate collagen fibril formation in skin, tendons, and other connective tissues. Pathogenic variants can cause classical Ehlers-Danlos syndrome with tissue fragility, hyperextensible skin, and joint hypermobility.
12 ClinVar pathogenic / likely pathogenic and 635 uncertain variants in COL5A2 have source records linked to Ehlers-Danlos syndrome, classic type, 1. Association strength is not clinical gene validity.
COL1A1: Collagen alpha-1(I) chain
The alpha-1 chain of type I collagen, the main fibrillar collagen in connective tissue, bone, and skin. Together with its partner chain, it forms strong extracellular fibers, and COL1A1 variants are associated with osteogenesis imperfecta and several Ehlers-Danlos syndromes.
0 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in COL1A1 have source records linked to Ehlers-Danlos syndrome, classic type, 1. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): TGFBR1.
ClinVar pathogenic and likely pathogenic variants linked to Ehlers-Danlos syndrome, classic type, 1
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| COL1A2 G193S | 193 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G280S | 280 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G292S | 292 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G337S | 337 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G391S | 391 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G592S | 592 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G613R | 613 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G613E | 613 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G625C | 625 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G631D | 631 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G631V | 631 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G766S | 766 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G772S | 772 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G112V | 112 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G118V | 118 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G190E | 190 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G196C | 196 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G202D | 202 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G205D | 205 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G247C | 247 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G256V | 256 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G265D | 265 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G265V | 265 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G274V | 274 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G277A | 277 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G280C | 280 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G286A | 286 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G286S | 286 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G292R | 292 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G292C | 292 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G298S | 298 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G319E | 319 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G325R | 325 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G349S | 349 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G493E | 493 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G505S | 505 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G598A | 598 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G661R | 661 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G661C | 661 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G664R | 664 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G664D | 664 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G676A | 676 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G679S | 679 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G700R | 700 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G700C | 700 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G766R | 766 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G769C | 769 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G772R | 772 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G775E | 775 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G817E | 817 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G913D | 913 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G913S | 913 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G919S | 919 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G1093R | 1093 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G1093C | 1093 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 D1120N | 1120 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G130D | 130 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G151R | 151 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G211D | 211 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G220D | 220 | Pathogenic / likely pathogenic (★★) |
Showing 60 of 296.
Uncertain variants prioritized for review in Ehlers-Danlos syndrome, classic type, 1
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| COL1A2 G163S | 163 | Conflicting reports (★) | +7: 3 other pathogenic changes within 3 positions; G163V at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.969 | |
| COL1A2 G961V | 961 | Conflicting reports (★) | +7: G961D at the same position is pathogenic; seen in 3.4e-06 of gnomAD DNA copies; REVEL 0.972 | |
| COL5A2 G324S | 324 | Uncertain (★) | +7: G324D at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.965 | |
| COL1A2 K264E | 264 | Uncertain (★★) | +7: 6 other pathogenic changes within 3 positions; K264N at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.835 | |
| COL5A1 G478C | 478 | Interrupted collagenous region | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; G478A at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97 |
| COL5A1 G1489E | 1489 | Triple-helical region | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; G1489R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| COL5A1 G481V | 481 | Interrupted collagenous region | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; G481R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
| COL5A1 G478S | 478 | Interrupted collagenous region | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; G478A at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.79 |
| COL1A2 D1120E | 1120 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; D1120N at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.80 |
Which prediction tools work for Ehlers-Danlos syndrome, classic type, 1
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 97 out of 100
- MetaLR: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 94 out of 100
- PolyPhen-2: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 91 out of 100
- phyloP: 90 out of 100
- SIFT: 90 out of 100
- SpliceAI: 50 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 48 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Osteogenesis imperfecta also has ClinVar records linked to COL1A2 variants; they fall in the same places as the Ehlers-Danlos syndrome, classic type, 1 variants (332 pathogenic / likely pathogenic).
- Osteogenesis imperfecta with normal sclerae, dominant form also has ClinVar records linked to COL1A2 variants; they fall in the same places as the Ehlers-Danlos syndrome, classic type, 1 variants (51 pathogenic / likely pathogenic).
- Osteogenesis imperfecta, perinatal lethal also has ClinVar records linked to COL1A2 variants; they fall in the same places as the Ehlers-Danlos syndrome, classic type, 1 variants (42 pathogenic / likely pathogenic).
- Combined osteogenesis imperfecta and Ehlers-Danlos syndrome also has ClinVar records linked to COL1A2 variants; they fall in the same places as the Ehlers-Danlos syndrome, classic type, 1 variants (11 pathogenic / likely pathogenic).
- Ehlers-Danlos syndrome, arthrochalasia also has ClinVar records linked to COL1A2 variants; they fall in the same places as the Ehlers-Danlos syndrome, classic type, 1 variants (7 pathogenic / likely pathogenic).
- Familial thoracic aortic aneurysm and aortic dissection also has ClinVar records linked to COL5A1 variants; they fall mostly in different places as the Ehlers-Danlos syndrome, classic type, 1 variants (3 pathogenic / likely pathogenic).
Diseases related to Ehlers-Danlos syndrome, classic type, 1
- Ehlers-Danlos syndrome, also linked to COL1A1, COL1A2, COL5A1 and COL5A2
- Connective tissue disease, also linked to COL1A1, COL1A2, COL5A1 and COL5A2
- Familial thoracic aortic aneurysm and aortic dissection, also linked to COL5A1 and COL5A2
- Osteogenesis imperfecta, also linked to COL1A1 and COL1A2
- Osteogenesis imperfecta, perinatal lethal, also linked to COL1A1 and COL1A2
- Osteogenesis imperfecta with normal sclerae, dominant form, also linked to COL1A1 and COL1A2
- Ehlers-Danlos syndrome, arthrochalasia, also linked to COL1A1 and COL1A2
- Combined osteogenesis imperfecta and Ehlers-Danlos syndrome, also linked to COL1A1 and COL1A2
- Osteoporosis, also linked to COL1A1 and COL1A2
- Postmenopausal osteoporosis, also linked to COL1A1 and COL1A2
- Phenylketonuria, also linked to COL1A1
- Caffey disease, also linked to COL1A1
Frequently asked questions
Which genes have records linked to Ehlers-Danlos syndrome, classic type, 1?
This view contains 4 analyzed proteins: COL1A2, COL5A1, COL5A2, COL1A1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 296 pathogenic or likely pathogenic variants, 1,416 variants of uncertain significance and 564 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 9 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 2,629 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center